MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
154.58%
Quick Ratio
103.44%
Cash Ratio
43.92%
Debt to Asset Ratio
70.82%
Unit: Thousand (K) dollars
Assets Breakdown
    • Accounts receivable, net of allo...
    • Cash and restricted cash
    • Intangible assets, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Convertible preferred stock, 0.0...
    • Others
Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and restricted cash
3,993
1,169
2,722
5,242
Restricted cash
-
0
0
-
Accounts receivable, net of allowances of 50 and 27, respectively
4,537
7,308
6,048
4,533
Inventories
4,649
4,822
5,023
5,439
Prepaid expenses and other current assets
874
750
1,003
760
Total current assets
14,053
14,049
14,796
15,974
Property and equipment, net
1,115
1,288
1,237
1,435
Right-of-use assets
343
532
632
730
Intangible assets, net
3,418
3,500
4,152
4,235
Goodwill
431
431
431
431
Other assets
308
311
413
362
Total assets
19,668
20,111
21,661
23,167
Accounts payable
2,109
1,431
1,661
1,448
Accrued liabilities
1,723
1,779
1,930
1,760
Deferred revenues, current
1,583
1,727
1,700
1,808
Convertible promissory note, net
2,075
2,008
1,937
-
Notes payable, current
1,250
1,250
1,250
1,250
Lease liabilities, current
351
441
461
448
Total current liabilities
9,091
8,636
8,939
6,714
Deferred revenues
1,261
1,414
1,631
1,689
Notes payable, net
520
798
1,070
3,335
Lease liabilities
121
147
237
358
Warrant liabilities
2,863
0
0
0
Other non-current liabilities
72
89
105
141
Total liabilities
13,928
11,084
11,982
12,237
Convertible preferred stock, 0.001 par value 10,000 shares authorized 6 and 0 issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
3,650
-
-
-
Common stock, 0.001 par value 141,429 shares authorized 3,563 and 3,559 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
37
37
36
36
Additional paid-in capital
271,816
272,078
268,065
267,878
Accumulated other comprehensive loss
-482
-692
-700
-683
Accumulated deficit
-269,281
-262,396
-257,722
-256,301
Total stockholders equity
2,090
9,027
9,679
10,930
Total liabilities and stockholders equity
19,668
20,111
21,661
23,167
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Inventories$4,649K Accounts receivable, netof allowances of 50...$4,537K Cash and restrictedcash$3,993K Prepaid expenses andother current assets$874K Total current assets$14,053K Intangible assets, net$3,418K Property and equipment,net$1,115K Goodwill$431K Right-of-use assets$343K Other assets$308K Total assets$19,668K Total liabilities andstockholders equity$19,668K Total liabilities$13,928K Convertible preferredstock, 0.001 par value...$3,650K Total stockholdersequity$2,090K Accumulated deficit-$269,281K Accumulated othercomprehensive loss-$482K Total currentliabilities$9,091K Warrant liabilities$2,863K Deferred revenues$1,261K Notes payable, net$520K Lease liabilities$121K Other non-currentliabilities$72K Additional paid-in capital$271,816K Common stock, 0.001 parvalue 141,429 shares...$37K Accounts payable$2,109K Convertible promissorynote, net$2,075K Accrued liabilities$1,723K Deferred revenues,current$1,583K Notes payable,current$1,250K Lease liabilities,current$351K

EKSO BIONICS HOLDINGS, INC. (EKSO)

EKSO BIONICS HOLDINGS, INC. (EKSO)